Future research priorities should include defining optimal therapeutic sequencing and optimal combination strategies with cardiometabolic agents, including glucagon-like peptide 1 receptor agonists and non-steroidal mineralocorticoid receptor antagonists, refining perioperative interruption management, evaluating primary prevention in high-risk populations and strengthening clinical implementation strategies
To view or add a comment, sign in Among adults with type 2 diabetes, #GlucagonLikePeptide1 receptor agonist initiation was associated with lower 3-year fragility fracture risk vs #DipeptidylPeptidase4 inhibitor initiation
See our storage guide linked above for full handling details relevant to liquid peptide formats
Deconvoluting the biology and druggability of protein lipidation using chemical proteomics
Interleukin-1 inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
Nayan Patel: I have skincare line forever, but I only, I give it to my wife and her friends and family, and that's all the people that bought it